Literature DB >> 26438792

Role of B cells in host defense against primary Coxiella burnetii infection.

Laura Schoenlaub1, Alexandra Elliott1, Danielle Freches1, William J Mitchell1, Guoquan Zhang2.   

Abstract

Despite Coxiella burnetii being an obligate intracellular bacterial pathogen, our recent study demonstrated that B cells play a critical role in vaccine-induced immunity to C. burnetii infection by producing protective antibodies. However, the role of B cells in host defense against primary C. burnetii infection remains unclear. In this study, we investigated whether B cells play an important role in host defense against primary C. burnetii infection. The results showed that peritoneal B cells were able to phagocytose virulent C. burnetii bacteria and form Coxiella-containing vacuoles (CCVs) and that C. burnetii can infect and replicate in peritoneal B1a subset B cells in vitro, demonstrating a potential role for peritoneal B cells in host defense against C. burnetii infection in vivo. In addition, the results showing that B1a cells secreted a high level of interleukin-10 (IL-10) in response to C. burnetii infection in vitro suggest that B1a cells may play an important role in inhibiting the C. burnetii infection-induced inflammatory response. The observation that adoptive transfer of peritoneal B cells did not significantly affect the severity of C. burnetii infection-induced diseases in both severe combined immunity-deficient (SCID) and μMT mice indicates that peritoneal B cells alone may not be able to control C. burnetii infection. In contrast, our finding that C. burnetii infection induced more-severe splenomegaly and a higher bacterial burden in the spleens of B1a cell-deficient Bruton's tyrosine kinase x-linked immunity-deficient (BTK(xid)) mice than in their wild-type counterparts further suggests that B1a cells play an important role in host defense against primary C. burnetii infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26438792      PMCID: PMC4645393          DOI: 10.1128/IAI.01073-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE.

Authors:  R A ORMSBEE; E J BELL; D B LACKMAN; G TALLENT
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  B cells play a regulatory role in mice infected with the L3 of Brugia pahangi.

Authors:  Victoria Gillan; Rachel A Lawrence; Eileen Devaney
Journal:  Int Immunol       Date:  2005-02-21       Impact factor: 4.823

3.  National surveillance and the epidemiology of human Q fever in the United States, 1978-2004.

Authors:  Jennifer H McQuiston; Robert C Holman; Candace L McCall; James E Childs; David L Swerdlow; Herbert A Thompson
Journal:  Am J Trop Med Hyg       Date:  2006-07       Impact factor: 2.345

4.  Helminth infection protects mice from anaphylaxis via IL-10-producing B cells.

Authors:  Niamh E Mangan; Rosemary E Fallon; Philip Smith; Nico van Rooijen; Andrew N McKenzie; Padraic G Fallon
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

5.  B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae.

Authors:  Karen M Haas; Jonathan C Poe; Douglas A Steeber; Thomas F Tedder
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

Review 6.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  Microbicidal property of B1 cell derived mononuclear phagocyte.

Authors:  A F Popi; D S Zamboni; R A Mortara; M Mariano
Journal:  Immunobiology       Date:  2009-03-24       Impact factor: 3.144

Review 8.  Regulatory B cells as inhibitors of immune responses and inflammation.

Authors:  Jean-David Bouaziz; Koichi Yanaba; Thomas F Tedder
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

9.  Isolation of mouse peritoneal cavity cells.

Authors:  Avijit Ray; Bonnie N Dittel
Journal:  J Vis Exp       Date:  2010-01-28       Impact factor: 1.355

10.  Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent.

Authors:  Jeffrey G Shannon; Diane C Cockrell; Kazue Takahashi; Gregory L Stahl; Robert A Heinzen
Journal:  BMC Immunol       Date:  2009-05-08       Impact factor: 3.615

View more
  9 in total

1.  Coxiella burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells.

Authors:  Laura Schoenlaub; Rama Cherla; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

2.  IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections.

Authors:  John M Leech; Keenan A Lacey; Michelle E Mulcahy; Eva Medina; Rachel M McLoughlin
Journal:  J Immunol       Date:  2017-02-06       Impact factor: 5.422

3.  Bruton's Tyrosine Kinase Deficiency Ameliorates Antimicrobial Host Defense during Peritonitis Induced by Pathogenic Escherichia coli.

Authors:  Zhe Liu; Cornelis van 't Veer; Rudi W Hendriks; Joris J T H Roelofs; Tom van der Poll; Alex F de Vos
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

4.  To die or not to die: Programmed cell death responses and their interactions with Coxiella burnetii infection.

Authors:  Chelsea A Osbron; Alan G Goodman
Journal:  Mol Microbiol       Date:  2022-02-02       Impact factor: 3.979

5.  Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.

Authors:  Svea Matthiesen; Luca Zaeck; Kati Franzke; Rico Jahnke; Charlie Fricke; Michael Mauermeir; Stefan Finke; Anja Lührmann; Michael R Knittler
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

6.  Brucella Omp25 Upregulates miR-155, miR-21-5p, and miR-23b to Inhibit Interleukin-12 Production via Modulation of Programmed Death-1 Signaling in Human Monocyte/Macrophages.

Authors:  Beibei Cui; Wenli Liu; Xiaoya Wang; Yu Chen; Qian Du; Xiaomin Zhao; Hai Zhang; Shan-Lu Liu; Dewen Tong; Yong Huang
Journal:  Front Immunol       Date:  2017-06-26       Impact factor: 7.561

Review 7.  Effects of BTK signalling in pathogenic microorganism infections.

Authors:  Bingjue Ye; Cheng Zhou; Huiting Guo; Min Zheng
Journal:  J Cell Mol Med       Date:  2019-08-08       Impact factor: 5.310

8.  Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells.

Authors:  Monika Bednarczyk; Carolina Medina-Montano; Frederic Julien Fittler; Henner Stege; Meike Roskamp; Michael Kuske; Christian Langer; Marco Vahldieck; Evelyn Montermann; Ingrid Tubbe; Nadine Röhrig; Andrzej Dzionek; Stephan Grabbe; Matthias Bros
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

9.  Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease.

Authors:  Xianyi Meng; Bettina Grötsch; Yubin Luo; Karl Xaver Knaup; Michael Sean Wiesener; Xiao-Xiang Chen; Jonathan Jantsch; Simon Fillatreau; Georg Schett; Aline Bozec
Journal:  Nat Commun       Date:  2018-01-17       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.